bcs-based biowaiver: experimental assessment of (quantitative)...
TRANSCRIPT
![Page 1: BCS-based biowaiver: Experimental assessment of (quantitative) …events.acdima.com/wp-content/uploads/2018/05/180502-GBHI... · 2018. 5. 2. · 4 › 1991 foundation of HWI pharma](https://reader035.vdocuments.net/reader035/viewer/2022071514/6135bd560ad5d20676479192/html5/thumbnails/1.jpg)
BCS-based biowaiver: Experimental assessment of
(quantitative) composition of the reference product
3rd Symposium on Harmonization of Bioequivalence Requirements
Amman, May, 2nd/3rd 2018
![Page 2: BCS-based biowaiver: Experimental assessment of (quantitative) …events.acdima.com/wp-content/uploads/2018/05/180502-GBHI... · 2018. 5. 2. · 4 › 1991 foundation of HWI pharma](https://reader035.vdocuments.net/reader035/viewer/2022071514/6135bd560ad5d20676479192/html5/thumbnails/2.jpg)
www.hwi-group.de
1. HWI group
2. Analytical techniques: advantageous and limitations
3. Examples demonstrating challenges and solutions
Agenda
2
![Page 3: BCS-based biowaiver: Experimental assessment of (quantitative) …events.acdima.com/wp-content/uploads/2018/05/180502-GBHI... · 2018. 5. 2. · 4 › 1991 foundation of HWI pharma](https://reader035.vdocuments.net/reader035/viewer/2022071514/6135bd560ad5d20676479192/html5/thumbnails/3.jpg)
www.hwi-group.de3
![Page 4: BCS-based biowaiver: Experimental assessment of (quantitative) …events.acdima.com/wp-content/uploads/2018/05/180502-GBHI... · 2018. 5. 2. · 4 › 1991 foundation of HWI pharma](https://reader035.vdocuments.net/reader035/viewer/2022071514/6135bd560ad5d20676479192/html5/thumbnails/4.jpg)
www.hwi-group.de
HWI group
4
› 1991 foundation of HWI pharma services GmbH, Ruelzheim by
Dr. Wissel and Prof. Häberlein
› 2006 foundation of i.DRAS GmbH, Planegg-Martinsried
› 2008 acquisition of the pharmaceutical development unit from
a CMO (HWI development, Appenweier)
› Today full service provider in the CMC field
› 160 employees (35% university graduates)
› GMP certificate, manufacturing licence (Ruelzheim and Appenweier site)
› Qualified Person (6), Qualified Person for Pharmacovigilance (6)
www.hwi.group.de
![Page 5: BCS-based biowaiver: Experimental assessment of (quantitative) …events.acdima.com/wp-content/uploads/2018/05/180502-GBHI... · 2018. 5. 2. · 4 › 1991 foundation of HWI pharma](https://reader035.vdocuments.net/reader035/viewer/2022071514/6135bd560ad5d20676479192/html5/thumbnails/5.jpg)
www.hwi-group.de5
Method development and validation
Purity testing of particular impurities – trace analysis
Structure elucidation
Trouble shooting (root cause analysis)
Extractables & Leachables testing
Batch release and stability testing
Reference standards for quality control
HWI group: Services for API, drug product & medical device
API characterisation and quality screening (up to OEB level 4)
Development of solid, semisolid and liquid dosage forms
Dry powder inhaler testing and development
Manufacturing of clinical batches
DoE approach
Laboratory services
Drug Development
![Page 6: BCS-based biowaiver: Experimental assessment of (quantitative) …events.acdima.com/wp-content/uploads/2018/05/180502-GBHI... · 2018. 5. 2. · 4 › 1991 foundation of HWI pharma](https://reader035.vdocuments.net/reader035/viewer/2022071514/6135bd560ad5d20676479192/html5/thumbnails/6.jpg)
www.hwi-group.de6
Compilation, review, assessment of IMPDs / IBs and dossiers
Management of MAA procedures
Technical documentations for medical devices
Drug-device combination products (EU/US)
Life-cycle management (dossier updates and variations)
HWI group: Services for API, drug product & medical device
GMP & GDP, GVP services
Compilation, revision and maintenance of package leaflets,
summaries of product characteristics (SmPCs) and labelling
Quality management services
Batch release, GMP-Audits
Regulatory affairs services
Vigilance & Quality Services
![Page 7: BCS-based biowaiver: Experimental assessment of (quantitative) …events.acdima.com/wp-content/uploads/2018/05/180502-GBHI... · 2018. 5. 2. · 4 › 1991 foundation of HWI pharma](https://reader035.vdocuments.net/reader035/viewer/2022071514/6135bd560ad5d20676479192/html5/thumbnails/7.jpg)
www.hwi-group.de
1. HWI group
2. Analytical techniques: advantageous and limitations
3. Examples demonstrating challenges and solutions
Agenda
7
![Page 8: BCS-based biowaiver: Experimental assessment of (quantitative) …events.acdima.com/wp-content/uploads/2018/05/180502-GBHI... · 2018. 5. 2. · 4 › 1991 foundation of HWI pharma](https://reader035.vdocuments.net/reader035/viewer/2022071514/6135bd560ad5d20676479192/html5/thumbnails/8.jpg)
www.hwi-group.de
Determination of the original drug product composition
(reverse engineering)
Reverse engineering is the decoding of an innovator product’s formulation
parameters.
Reverse engineering includes
› Qualitative and quantitative composition of the innovator product
› Solid-state characterization of the drug substance(s)
› Manufacturing process
The qualitative composition of the innovator product and the amount of the
API are known.
8
![Page 9: BCS-based biowaiver: Experimental assessment of (quantitative) …events.acdima.com/wp-content/uploads/2018/05/180502-GBHI... · 2018. 5. 2. · 4 › 1991 foundation of HWI pharma](https://reader035.vdocuments.net/reader035/viewer/2022071514/6135bd560ad5d20676479192/html5/thumbnails/9.jpg)
www.hwi-group.de
Quantitation of excipients
1. Step: Separation of excipients from matrix (e.g. tablet)
› Differential solubility
› Filtration, centrifugation, chromatography
2. Step: Detection of separated excipients
› Gravimetric methods (major excipients of significant weight in the
dosage unit!)
› Spectroscopic methods (UV/VIS, Fluorescence, Light scattering, MS,
qNMR)
› Refractive index
9
![Page 10: BCS-based biowaiver: Experimental assessment of (quantitative) …events.acdima.com/wp-content/uploads/2018/05/180502-GBHI... · 2018. 5. 2. · 4 › 1991 foundation of HWI pharma](https://reader035.vdocuments.net/reader035/viewer/2022071514/6135bd560ad5d20676479192/html5/thumbnails/10.jpg)
www.hwi-group.de
Quantification of excipients
Organic components
› HPLC
› GC (volatile components, residue solvents, flavours)
› HPTLC (components without chromophores, e.g. sugars)
› Size exclusion chromatography (for high molecular weight excipients)
› Hyphenated techniques using spectroscopic detection: LC-MS, GC-MS, LC-
NMR, LC-SPE/NMR
› Benefits:
› small amounts of organic excipients are best quantified using
sophisticated separation and quantification techniques
› Coupling experiments for separation of mixtures
› high selectivity and sensitivity
› Limitation: solubility of excipients!10
![Page 11: BCS-based biowaiver: Experimental assessment of (quantitative) …events.acdima.com/wp-content/uploads/2018/05/180502-GBHI... · 2018. 5. 2. · 4 › 1991 foundation of HWI pharma](https://reader035.vdocuments.net/reader035/viewer/2022071514/6135bd560ad5d20676479192/html5/thumbnails/11.jpg)
www.hwi-group.de
Quantification of excipients
Inorganic Components, Counter-ions
› Titration (specific but not selective!)
› Atomic absorption spectroscopy (AAS)
› ICP-MS
› Scanning Electron Microscope/Energy Dispersive X-Ray (SEM-EDX)
Water
› Karl Fischer (small sample quantity -> coulometric detection)
11
![Page 12: BCS-based biowaiver: Experimental assessment of (quantitative) …events.acdima.com/wp-content/uploads/2018/05/180502-GBHI... · 2018. 5. 2. · 4 › 1991 foundation of HWI pharma](https://reader035.vdocuments.net/reader035/viewer/2022071514/6135bd560ad5d20676479192/html5/thumbnails/12.jpg)
www.hwi-group.de
Solid-state characterization of API
Polymorphic form, anhydrous form, hydrate, solvate
Impact on
› Dissolution profile
› Bioavailability
› Stability (chemical and physical)
› Processability (hygroscopicity, flow, compressability)
Techniques
› DSC, Powder X-ray diffraction (XRD), Thermogravimetric analysis (TGA),
FTIR, RAMAN
12
Molecular Properties
![Page 13: BCS-based biowaiver: Experimental assessment of (quantitative) …events.acdima.com/wp-content/uploads/2018/05/180502-GBHI... · 2018. 5. 2. · 4 › 1991 foundation of HWI pharma](https://reader035.vdocuments.net/reader035/viewer/2022071514/6135bd560ad5d20676479192/html5/thumbnails/13.jpg)
www.hwi-group.de
Solid-state characterization of APIs
Crystallinity, particle size (micronization!), particle shape, porosity
Impact on
› Dissolution profile
› Disintegration time
› Processability (hygroscopicity, flow, compressability, hardness)
Techniques
› PSD: Laser light scattering (Malvern Master Sizer®, Helos®), Stroboscopic light
scattering (PartAn®)
› Microscopy, X-ray micro tomography (XMT), SEM-EDX
Benefits
› not destroying methods , no solubility needed
› XMT, SEM-EDX: particle size min. 50 nm diameter (high resolution!)
› fast and inexpensive13
Particle Properties
![Page 14: BCS-based biowaiver: Experimental assessment of (quantitative) …events.acdima.com/wp-content/uploads/2018/05/180502-GBHI... · 2018. 5. 2. · 4 › 1991 foundation of HWI pharma](https://reader035.vdocuments.net/reader035/viewer/2022071514/6135bd560ad5d20676479192/html5/thumbnails/14.jpg)
www.hwi-group.de
Solid-state characterization of API
Bulk density, powder packaging, homogeneity
Impact on
› Flow properties
› Blending efficiency
› Capsule filling, Tablet size
› Compressibility
› Techniques
› Density testing, XMT, SEM-EDX
14
3. Bulk Properties
![Page 15: BCS-based biowaiver: Experimental assessment of (quantitative) …events.acdima.com/wp-content/uploads/2018/05/180502-GBHI... · 2018. 5. 2. · 4 › 1991 foundation of HWI pharma](https://reader035.vdocuments.net/reader035/viewer/2022071514/6135bd560ad5d20676479192/html5/thumbnails/15.jpg)
www.hwi-group.de
1. HWI group
2. Analytical techniques: advantageous and limitations
3. Examples demonstrating challenges and solutions
Agenda
15
![Page 16: BCS-based biowaiver: Experimental assessment of (quantitative) …events.acdima.com/wp-content/uploads/2018/05/180502-GBHI... · 2018. 5. 2. · 4 › 1991 foundation of HWI pharma](https://reader035.vdocuments.net/reader035/viewer/2022071514/6135bd560ad5d20676479192/html5/thumbnails/16.jpg)
www.hwi-group.de
XMT applications: hard gelatine capsule
› submicron resolution
› elucidation of internal structures
› quantification of internal pores, cracks, densities
XMT capsule example (Skyscan
1172, 15 µm spatial resolution)
16
![Page 17: BCS-based biowaiver: Experimental assessment of (quantitative) …events.acdima.com/wp-content/uploads/2018/05/180502-GBHI... · 2018. 5. 2. · 4 › 1991 foundation of HWI pharma](https://reader035.vdocuments.net/reader035/viewer/2022071514/6135bd560ad5d20676479192/html5/thumbnails/17.jpg)
www.hwi-group.de
XMT applications: tablet
17
Polymer matrix in tablet: Examination of homogeneity